The Landscape of Neuroblastoma in COG: Yesterday, Today and Tomorrow’s Therapies (C234)

coglogo 1CH Many advances in the therapy of children with neuroblastoma have been made in the past decade by the Children’s Oncology Group (COG). New trials build upon those successes in an attempt to reduce therapy for lower risk (LR) and intensify therapy for high risk (HR) disease patients.

Current therapies and the nursing care management of LR, HR and relapsed disease will be discussed.